Cart 0
Compare 0 Wishlist 0
My Account
Menu
₹134 850

Crizalk 250mg Capsule: Effective Medication for Your Health

Brand: PFIZER LTD
Product Code: MRM_101754
Reviews: (0)
In Stock
₹134 850
Buy in one click
Specifications: (see all)
Manufacturer
PFIZER LTD
Origin of Medicine
United States of America
Price for
60 Capsule(s) In A Box
Salt Composition
Crizotinib
Delivery Delivery from India within 15 days. Payment Pay quickly and conveniently Cumulative discounts Collect bonuses and gifts

Crizalk 250mg Capsule

Uses:

  • Treatment of Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic.

Therapeutic Effects:

  • Crizalk 250mg is a tyrosine kinase inhibitor that blocks the activity of the anaplastic lymphoma kinase (ALK) protein.
  • Specifically targets the abnormal protein and blocks its activity, slowing down or stopping the growth and spread of cancer cells.

Dosage and Administration:

  • Recommended dose: one capsule of 250 mg taken orally twice daily.
  • Swallow the capsules whole and do not crush, chew, dissolve, or open the capsules.
  • Dosage and administration frequency are chosen by the physician based on the medical condition.

Safety Advices:

  • Do not take if you are allergic to Crizotinib or any other ingredients of this medicine.
  • Inform your physician if you have had kidney, stomach, heart, or liver problems.
  • Notify your doctor if you have reduced white blood cells, abnormal heart tracing after ECG, vision problems, or if you take other medications.
  • Report your doctor immediately if you are planning to get pregnant or think you may be pregnant.
  • Use effective birth control during the treatment and for at least 90 days after completing the therapy.
  • Store at room temperature (15-30˚C) in the original container.
  • Keep out of the sight and reach of children.

Interaction with Other Drugs:

  • Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, recent vaccinations, nutritional and vitamin supplements, and herbal products.
  • Certain medications such as Erythromycin, Diltiazem, Verapamil, and others may interact with Crizalk 250mg and reduce its effectiveness.

Side Effects:

  • Serious: pain on the right of the stomach, partial or full loss of vision, lowered WBC, low heart rate, swelling of the lungs, breathlessness, cough with or without mucus.
  • Common: sensitivity to sunlight, diarrhea, fever, constipation, nausea, increased liver enzymes, decreased appetite, tiredness (fatigue), dizziness, neuropathy (weakness, tingling, or numbness in the nerve), dysgeusia (taste disorder), hypophosphataemia (low levels of phosphate in the blood).

FAQs:

  • Q 1. Does Crizalk 250mg cure cancer?
    • Crizalk 250mg is not a cure for cancer, but it can help to slow down or stop the growth and spread of cancer cells, improving the overall survival and quality of life of patients with certain types of cancer.
  • Q 2. What should I do if I miss a dose of Crizalk 250mg?
    • If you miss a dose of Crizalk 250mg, you should take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
  • Q 3. What should I tell my doctor before taking Crizalk 250mg?
    • Before taking Crizalk 250mg, you should tell your doctor if you have liver or kidney problems, a history of heart disease, or are pregnant or planning to become pregnant.
  • Q 4. Why there are low levels of phosphate in the blood while taking Crizalk 250mg?
    • The exact mechanism by which Crizalk 250mg causes hypophosphatemia (low level of phosphate) is not fully understood, but it is thought to be related to the inhibition of certain enzymes involved in phosphate transport and metabolism in the body.
  • Q 5. Can Crizalk 250mg be used in combination with other cancer medications?
    • Crizalk 250mg may be used in combination with the chemotherapy drugs Pemetrexed and Cisplatin in the first-line treatment of ALK-positive non-small cell lung cancer (NSCLC). It depends on the specific cancer diagnosis and treatment plan.

Fact Box:

  • Molecule name: Crizotinib
  • Therapeutic class: Antineoplastic drug
  • Pharmacological class: Tyrosine kinase inhibitors
  • Indication: Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC)

Tags: Crizalk, medication, health, pharmaceutical, capsule, 250mg, drug, medical, treatment

Основные характеристики
Manufacturer
PFIZER LTD
Origin of Medicine
United States of America
Price for
60 Capsule(s) In A Box
Salt Composition
Crizotinib
Reviews
0/ 5
average product rating
0
0
0
0
0
There are no reviews for this product. Be the first to leave your review.